Psychedelics Companies Face Off Against Big Pharma’s $6.8B Annual Ad Spend
With the psychedelics industry in a nascent stage, it’s easy for companies to overlook the importance of marketing—especially drug development companies without therapeutic products available to consumers. But according to Social Club TV CEO Joshua Otten, that is an incomplete perspective on things. With insufficient public awareness of the benefits of psychedelic product/services, and steep … Read more